Cover Image
市場調查報告書

疼痛管理藥及疼痛管理設備的全球市場

The Global Market for Pain Management Drugs and Devices

出版商 BCC Research 商品編碼 96391
出版日期 內容資訊 英文 251 pages
訂單完成後即時交付
價格
Back to Top
疼痛管理藥及疼痛管理設備的全球市場 The Global Market for Pain Management Drugs and Devices
出版日期: 2017年08月31日 內容資訊: 英文 251 pages
簡介

全球疼痛管理藥·疼痛管理設備的市場規模預測在2017年為361億美元,到2022年前將擴大到520億美元,並以7.6%的年複合成長率 (CAGR) 成長。

本報告提供全球疼痛治療藥及疼痛管理設備的市場相關分析,提供疾病的背景情況和技術·產品概要,全球各國的法規整備動向,市場基本結構及最新形勢,未來市場趨勢預測 (今後6年份),主要的促進·阻礙因素,今後的市場機會與課題,主要企業簡介等調查。

第1章 簡介

第2章 摘要和亮點

第3章 市場·技術的背景情況

  • 疼痛及疼痛治療的歷史
  • 疼痛的認識
  • 疼痛的種類:急性疼痛,慢性疼痛
  • 疼痛的評估:主觀/客觀的評估
  • 疼痛的診斷方法
  • 止痛方法
  • 人口的結構與高齡化
  • 疼痛管理治療:類固醇,內視鏡,螢光透視法
  • 替代性的疼痛管理手法
  • 藉由大麻的疼痛治療普及趨勢
  • 理學性的疼痛治療手法
    • 針灸/推拿
    • 冰 (冷凍療法)
    • 擴張關節的可動階段
    • 徒手整骨
    • 按摩
    • 牽引
    • 放射治療
    • 射頻神經消融術,硬薄膜外內視鏡手術
    • 手術
    • 漩渦浴(熱療)
  • 心理性疼痛治療
    • 生物回饋療法
    • 催眠療法
    • 行動修正/操作調節
    • 放鬆,壓力管理訓練
    • 印象療法
    • 自我訓練
    • 心理社會學的干預 (介入)
    • 分心·重塑
  • 補充性·替代性的疼痛管理手段:發展動向
  • 疼痛管理服務·機關
    • 家庭治療,安寧療護,醫院,解除痛苦療法,專門看護設施

第4章 產業的趨勢

  • 概要
    • 治療的問題
    • 止痛和專家所面臨的課題
    • 處方藥監測計劃
    • 就醫度
    • 管理護理疼痛管理問題
    • FDA (美國食品藥物管理局)的認證:疼痛治療藥
    • FDA的認證:疼痛管理設備
    • REMS (風險評估·緩和策略)
    • 普拿疼 (Acetaminophen)和FDA的變化
    • 治療咳嗽·感冒用的可待因(Codeine)
    • NSAID (非類固醇系抗發炎劑) 與心臟衰竭·中風的聯繫擴大
    • 藥物遞送·系統

第5章 疼痛治療:各產品種類

  • 概要
  • 疼痛的藥物治療
    • 治療疼痛用的處方藥
    • 市場全體
    • 麻醉劑止痛藥
    • 非麻醉劑止痛藥
    • 抗偏頭痛藥
    • 麻醉劑
    • 其他藥劑級
  • 疼痛管理設備
    • 疼痛管理設備市場
    • 市場全體
    • 脊椎刺激器
    • 組合型疼痛管理設備

第6章 各用途的市場區隔

  • 各用途的疼痛管理
    • 手術時的疼痛管理
    • 整形外科/肌肉骨骼治療相關的疼痛管理
    • 纖維肌痛症相關的疼痛管理
    • 癌症相關的疼痛管理
    • 神經病變性的疼痛管理
    • HIV/AIDS相關的疼痛管理
    • 燒燙傷相關的疼痛管理
    • 牙科相關的疼痛管理

第7章 各地區的市場區隔

  • 全球醫療指標
    • 醫療支出額和GDP分析
    • 平均住院日數
    • 全球各國的公共醫療制度
  • 全球各地的市場
    • 北美
    • 歐洲·中東·非洲各國 (EMEA)
    • 亞太地區
    • 南美

第8章 產業發展趨勢

  • 年表:產業的主要事件與趨勢
  • 醫藥品的開發平台
  • 疼痛管理設備臨床實驗趨勢
  • 專利分析
    • 各年度·各類型·各企業·各國·各申請人分析
    • 有代表性的治療藥的專利資訊
  • 品牌藥/學名藥的市場佔有率
  • 疼痛研究的未來性
    • 疼痛研究:兒童人口
    • 患者轉換期調查
    • 主要的疼痛相關的收購·聯盟

第9章 市場機會分析

  • 疼痛管理市場全體
    • 各類型·各用途·各地區的市場機會

第10章 企業簡介

附錄A:詞彙表和資訊來源

關於BCC Research

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: HLC026F

The global market for pain management will grow from nearly $36.1 billion in 2017 to $52.0 billion by 2022, with a compound annual growth rate (CAGR) of 7.6% for the period of 2017-2022.

Report Includes

  • An overview of the global market for pain management drugs, which will address acute vs. chronic pain, treatments, and issues facing healthcare workers
  • Analyses of global market trends, with data from 2015 and 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022
  • Examination of product categories, use of products, and the competitive landscape
  • Coverage of several significant market trends, including undertreatment issues, professional issues, managed care pain issues, trends in new therapies, product pipelines, generic participation, pain research, drug delivery, and patent expirations
  • Discussion of new regulatory requirements
  • Comprehensive company profiles of major players in the industry

Report Scope

This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global. This study will address acute versus chronic pain, treatments and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts and competitive analyses.

The report identifies two general segments of pain management:

  • Pharmaceuticals.
  • Devices.

Within the pharmaceuticals segment several sub-segments are discussed in detail including:

  • Narcotic pain management.
  • Non-narcotic pain management.
  • Antimigraine treatments.
  • Anesthetics.
  • Other drugs (including CNS therapies).

The device segment covers several product lines and specifically targets the largest product segments including:

  • Electrotherapy stimulators.
  • Spine stimulators.
  • Other products (including electromagnetic therapies and other treatments).

Each market segment provides detailed information based on product categories, product use, forecasts and competitive analyses.

Not covered in the report are drugs or devices that by treating the condition or disorder result in the relief of pain. These include treatments for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis or other similar diseases. Treatments are only included for those that indicate a relief of pain symptoms associated with these conditions.

A comparison of a treatment for the disease that naturally relieves the symptoms as compared to treatments for the relief of pain associated with the disease include:

  • Enbrel : Indicated for the treatment of moderate-to-severe rheumatoid arthritis.
  • Celebrex : Indicated for the treatment of the signs and symptoms of osteoarthritis and rheumatoid arthritis and the management of acute pain.

The report is also evaluated in terms of application, discussing market trends and performance for the following areas:

  • Surgical pain.
  • Orthopedic/musculoskeletal pain.
  • Migraine pain.
  • Fibromyalgia pain.
  • Cancer pain.
  • Neuropathic pain.
  • HIV/AIDS pain.
  • Dental pain.
  • General pain.

Analyst Credentials

MELISSA ELDER is a healthcare market analyst specializing in treatments, medical equipment and devices. As a research analyst for more than 20 years, she also worked in medical training and advanced medical technologies. She holds a B.S. degree in business management and is pursuing an MBA in health care management from California Coast University.

Table of Contents

Chapter 1: Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Methodology and Information Sources
  • Geographic Breakdown
  • Analyst's Credentials
  • Related BCC Research Reports

Chapter 2: Summary and Highlights

  • Overview
  • Summary of the Major Markets.
  • Market Trends
  • Undertreatment Issues
  • Professional Pain Treatment Issues
  • Access to Care
  • FDA Requirements for Approval of Pain Therapies
  • Drug Delivery Systems

Chapter 3: Market and Technology Background

  • History of Pain and Pain Treatment
  • The Perception of Pain
  • Types of Pain
    • Acute Pain
    • Chronic Pain
  • Assessment of Pain
    • Subjective
    • Objective
  • How Pain is Diagnosed
  • How Pain is Treated
  • Demographics and Aging Populations
    • Global Demographic Overview
    • Gender and Pain
    • Other Influences Determining How Pain is Felt Among Individuals
  • Pain Management Procedures: Steroids, Endoscopy, Fluoroscopy
  • Alternative Methods of Pain Management
  • Growing Trend in Cannabis Treatment for Pain
  • Physical Pain Treatment Modalities
    • Acupuncture/Acupressure
    • Ice (Cryotherapy)
    • Joint Mobilization
    • Manipulation
    • Massage
    • Traction
    • Radiation Therapy
    • Radio-Frequency Neuroablation, Epiduroscopy
    • Surgery
    • Whirlpool Bath (Thermotherapy)
  • Psychological Pain Therapies
    • Biofeedback
    • Hypnosis
    • Behavior Modification/Operant Conditioning
    • Relaxation and Stress Management Training
    • Imagery
    • Autogenic Training
    • Psychosocial Interventions
    • Distraction and Reframing.
  • Tracking the Development of Complementary and Alternative Pain Control Methods
  • Pain Management Services and Organizations
    • Home Care
    • Hospice
    • Hospitals
    • Pain Clinics
    • Skilled Nursing Facilities

Chapter 4: Industry Trends

  • Overview
    • Undertreatment Issues
    • Treatment of Pain and Issues Facing the Professional Segment
    • Prescription Drug Monitoring Programs
    • Access to Care
    • Managed Care Pain Management Issues
    • FDA Approval of Pain Therapies
    • FDA Approval of Pain Devices
    • Risk Evaluation and Mitigation Strategy (REMS)
    • Acetaminophen and FDA Changes
    • Codeine in Cough and Cold Medications
    • NSAIDs Linked to Increased Risk of Heart Attack or Stroke
    • Drug Delivery Systems

Chapter 5: Treating Pain: Markets by Product Type

  • Overview
  • Pharmaceutical Pain Management
    • Prescription Pain Management Products
    • Total Market
    • Narcotic Analgesics.
    • Non-narcotic Analgesics
    • Antimigraine Agents
    • Anesthetics
    • Other Drug Classes
  • Pain Management Devices
    • Pain Management Device Market
    • Total Market
    • Stimulation Therapy
    • Combination Pain Management Devices

Chapter 6: Market Breakdown by Application

  • Pain Management by Application
    • Surgical Pain Management
    • Orthopedic/Musculoskeletal Pain Management
    • Fibromyalgia Pain
    • Cancer Pain Management
    • Neuropathic Pain
    • HIV/AIDS Related Pain
    • Burn Pain
    • Dental Pain

Chapter 7: Market Breakdown by Region

  • Global Health Indicators
    • Health Expenditures and GDP Review
    • Average Length of Stay
    • Public Healthcare Systems Around the World
  • Markets by Global Region
    • North America
    • Europe, Middle East, Africa (EMEA)
    • Asia-Pacific
    • Latin America

Chapter 8: Industry Developments

  • Timeline of Significant Industry Events and Developments
  • Pharmaceutical Pipeline
  • Pain Device Clinical Trials
  • Patent Analysis
    • Patent Review by Year
    • Patent Review by Type
    • Patent Review by Company
    • Patent Review by Country
    • Patent Review by Assignee.
    • Drug Patents for Selected Therapies
  • The Brand/Generic Market Split
  • Future of Pain Research
    • Pain Research: Pediatric Populations
    • Patient Outcomes Research
    • Selected Pain-related Acquisitions and Alliances

Chapter 9: Analysis of Market Opportunities

  • Total Pain Management Market
    • Markets by Type
    • Markets by Application
    • Markets by Global Region

Chapter 10: Company Profiles

Appendix A: Terminology and Sources of Information

  • Pain Management Pharmaceutical Manufacturers and Developers
  • U.S. Pain Societies and Associations
  • International Associations and Organizations

About BCC Research

  • About BCC Research
  • BCC Membership
  • BCC Custom Research

List of Tables

  • Summary Table: Global Market for Pain Management, by Major Segment, Through 2022 ($ Millions)
  • Table 1 Objective Signs of Pain
  • Table 2 Global Population Growth, by Select Country, 2015 and 2020 (Millions)
  • Table 3 Global Population Growth, by Age Group, Through 2050 (Millions)
  • Table 4 Global Life Expectancy at Birth, by Select Country, 1980-2020 (Years)
  • Table 5 Pain by Select Category and Gender in the Age 18+ U.S. Population,* 1997-2010 (Thousands)
  • Table 6 U.S. Medical Marijuana Programs, by State
  • Table 7 Effectiveness of Fibromyalgia Treatments: Cannabis vs. Pharmaceutical Therapies, 2014 (%)
  • Table 8 Use of Complementary and Alternative Medicine Among U.S. Adults, by Type of Therapy, 2002-2015 (Thousands)
  • Table 9 Percentage of U.S. Hospice Patients, by Gender and Age Group, 2009-2014
  • Table 10 Percentage of Hospice Admissions, by Primary Diagnosis, 2009-2014 (% of Total)
  • Table 11 NHPCO Committees
  • Table 12 Definition of Pain Clinics
  • Table 13 Desirable Characteristics of Pain Clinics, by Type
  • Table 14 Registered Pain Clinics in the United States, by Top Metro Area, 2016 (Number)
  • Table 15 Registered Pain Clinics, by Country (Number)
  • Table 16 Availability of Education in Pain Management, by Select Region/Country
  • Table 17 Agency Responsible for PDMP in Each State
  • Table 18 Benefits of Prescription Monitoring Programs for Medical Boards
  • Table 19 Drugs Monitored by PDMPS, as of June 2017
  • Table 20 States with Electronic Prescription Monitoring Programs, as of June 2017
  • Table 21 Nurse Continuing Education Requirements for Pain Management, by Requiring State
  • Table 22 WHO List of Essential Medicines for Adult Pain Management
  • Table 23 Availability of Injectable Morphine, by Region/Country
  • Table 24 Availability of Oral Morphine in Hospice-Type Settings, by Region/Country
  • Table 25 FDA Analgesia/Anesthesia Drug Shortages, June 2017
  • Table 26 Parts 862-892 of 21 CFR
  • Table 27 List of Extended-Release and Long-Acting Opioid Products Subject to Opioid REMS, by Brand Name Product, May 2017
  • Table 28 List of Extended-Release and Long-Acting Opioid Products Subject to Opioid REMS, by Generic Product, May 2017
  • Table 29 List of Products Subject to the TIRF REMS Access Program, 2011-2016
  • Table 30 List of NSAIDs
  • Table 31 Advantages of Iontophoretic Drug Delivery
  • Table 32 FDA Applications/Approvals, Jan. 2010 Through Jan. 2017
  • Table 33 Global Market for Prescription Pain Management Pharmaceuticals, by Product, Through 2022 ($ Millions)
  • Table 34 Most Commonly Used General Anesthetic Agents
  • Table 35 Global Market for Pain Management Devices, by Technology Type, Through 2022 ($ Millions)
  • Table 36 Global Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 37 Global Market for Surgical Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 38 Birth Rates and Births, by Country, 2016 and 2025 (Thousands)
  • Table 39 Global Market for Orthopedic/Musculoskeletal Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 40 Global Market for Migraine/Headache Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 41 Global Market for Fibromyalgia Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 42 Cancer Pain Medication
  • Table 43 Global Market for Cancer Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 44 Global Market for Neuropathic Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 45 Global Market for HIV/AIDS Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 46 Global Market for Burn Pain Management, by Product Type, Through 2022 ($ Millions)
  • Table 47 Global Market for Dental Pain Management, Through 2022 ($ Millions)
  • Table 48 Health Expenditures as a Percentage of GDP, by Select Country, 1980-2015 (%)
  • Table 49 Average Hospital Length of Stay, by Select Country, 1970-2015 (Days)
  • Table 50 World Health Organization Ranking of Healthcare Systems, 2000
  • Table 51 Major Countries, by Region
  • Table 52 Global Market for Pain Management, by Region, Through 2022 ($ Millions)
  • Table 53 North American Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 54 EMEA Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 55 Asia-Pacific Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 56 Latin America Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 57 Select Pain Management Drug Pipelines
  • Table 58 Selected Pain Management Device Trials
  • Table 59 U.S. Patents on Pain Treatments, Issued, by Year, Jan. 2000 Through March 2017 (Number)
  • Table 60 Number of U.S. Patents on Pain Technologies, by Abstract Description
  • Table 61 U.S. Patents on Recent Pain Technologies, March 21, 2017-April 18, 2017
  • Table 62 U.S. Patent Expiration Dates for Select Pain Drugs
  • Table 63 First Time Prescription Generic Pain Management and Approvals, April 2005-June 2017
  • Table 64 Pain or Pain-related Clinical Trials, by Region, 2017
  • Table 65 Market Opportunities for Pain Management Treatments, Through 2022
  • Table 66 Global Market for Pain Management, by Major Type, Through 2022 ($ Millions)
  • Table 67 Global Market for Pain Management, by Application, Through 2022 ($ Millions)
  • Table 68 Global Market for Pain Management, by Region, Through 2022 ($ Millions)
  • Table 69 Abbott Laboratories Financials, Through 2016 ($ Millions)
  • Table 70 AbbVie Financials, Through 2016 ($ Millions)
  • Table 71 Allergan Financials, Through 2016 ($ Millions)
  • Table 72 AstraZeneca Financials, Through 2016 ($ Millions)
  • Table 73 Boston Scientific Financials, Through 2016 ($ Millions)
  • Table 74 Depomed Financials, Through 2016 ($ Millions)
  • Table 75 DJO Global financials, Through 2016 ($ Millions)
  • Table 76 Eli Lilly & Co. Financials, Through 2016 ($ Millions)
  • Table 77 Endo International Financials, Through 2016 ($ Millions)
  • Table 78 GlaxoSmithKline Financials, Through 2016 ($ Millions)
  • Table 79 Grünenthal Financials, Through 2016 ($ Millions)
  • Table 80 Hisamitsu Pharmaceutical financials, Through Fiscal 2017 ($ Millions)
  • Table 81 Johnson & Johnson Financials, Through 2016 ($ Millions)
  • Table 82 Medtronic Financials, Through Fiscal Year 2016 ($ Millions)
  • Table 83 Novartis Financials, Through 2016 ($ Millions)
  • Table 84 Pfizer Financials, Through 2016 ($ Millions)
  • Table 85 Glossary of terms used in Pain Management Drug and Device Markets
  • Table 86 Pain Management Pharmaceutical Manufacturers and Developers
  • Table 87 U.S. Pain Societies and Associations
  • Table 88 International Associations and Organizations

List of Figures

  • Summary Figure: Global Market for Pain Management, by Major Segment, 2014-2022 ($ Millions)
  • Figure 1 Pain Management Techniques
  • Figure 2 Global Population, by Select Country, 2015 and 2020 (Millions)
  • Figure 3 Global Population Growth, by Age Group, 2000-2050 (Millions)
  • Figure 4 Global Life Expectancy at Birth, 1980-2020 (Years)
  • Figure 5 Pain by Select Category and Gender in the 18+ U.S. Population,* 1997-2010 (%)
  • Figure 6 Use of Complementary and Alternative Medicine Among U.S. Adults, by Type of Therapy, 2002-2015 (Thousands)
  • Figure 7 Annual Number of U.S. Hospice Patients, 2009-2014
  • Figure 8 Percentage of U.S. Hospice Patients, by Gender, 2014 (%)
  • Figure 9 Percentage of U.S. Hospice Patients, by Age Group, 2014 (%)
  • Figure10 Distribution of Causes of Mortality and Potential Need for Palliative Care (Millions)
  • Figure 11 Distribution of Narcotic Drug Consumption, by Country (All Narcotic Types) (%)
  • Figure 12 Distribution of Morphine Consumption by Region/Country, 2015 (%)
  • Figure 13 Obstacles to Availability of Opioids for Medical Needs (Number)
  • Figure 14 Global Market for Prescription Pain Management Pharmaceuticals, by Product, 2014-2022 ($ Millions)
  • Figure 15 Global Market Distribution for Narcotic Analgesics, by Ingredient*, 2017 (%)
  • Figure 16 Global Market Distribution for Non-Narcotic Analgesics, by Ingredient*, 2017 (%)
  • Figure 17 Global Market Distribution for Antimigraine Agents, by Ingredient*, 2017 (%)
  • Figure 18 Global Market Distribution for Anesthetics, by Ingredient*, 2017 (%)
  • Figure 19 Global Market for Pain Management Devices, by Technology Type, 2014-2022 ($ Millions)
  • Figure 20 Global Market for Pain Management, by Application, 2014-2022 ($ Millions)
  • Figure 21 Global Market for Surgical Pain Management, by Product Type, 2014-2022 ($ Millions)
  • Figure 22 Births, by Country, 2016 and 2025
  • Figure 23 Arthritis Impact, Global Prevalence, by Year, 2000-2050
  • Figure 24 Global Cancer Mortality by Select Country per 100,000 Population, 1960-2020
  • Figure 25 Causes of Cancer Pain
  • Figure 26 Burn Pain Management Approach
  • Figure 27 Health Expenditures as a Percentage of GDP, by Select Country, 1980-2015 (%)
  • Figure 28 Global Market for Pain Management, by Region, 2014-2022 ($ Millions)
  • Figure 29 Pain Management Drug Pipeline, by Development Status (Number)
  • Figure 30 Pain Management Drug Pipeline, by Primary Indication (Number)
  • Figure 31 Pain Management Devices in Development, by Development Status (%)
  • Figure 32 Shares of U.S. Patents on Pain Technologies, by Three-Year Date Range, Jan 2000-March 2017 (%)
  • Figure 33 Shares of U.S. Patents on Pain Technologies, by Abstract Description (%)
  • Figure 34 Patent Shares of Pain Technologies (%)
  • Figure 35 Global Market for Pain Management Pharmaceuticals, by Actual and Projected Brand vs. Generic Sales Performance, 2012-2022 ($ Millions)
  • Figure 36 Distribution of Pain-related Clinical Trials for All Ages, by Region, 2017 (%)
  • Figure 37 Distribution of Pain-related Clinical Trials for Pediatrics, by Region, 2017 (%)
  • Figure 38 Global Market for Pain Management, 2015-2022 ($ Millions)
  • Figure 39 Global Market for Pain Management, by Major Type, 2014-2022 ($ Millions)
  • Figure 40 Global Market for Pain Management, by Application, 2014-2022 ($ Millions)
  • Figure 41 Global Market for Pain Management, by Region, 2014-2022 ($ Millions)
Back to Top